{"symbol":"LLY","fiscalQuarter":"Q2-2013","reportDate":"2013-07-24","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q2-2013","postBrief":{"headline":"Eli Lilly Beats on EPS, Stock Up 3.06%","keyNumbers":[{"metric":"EPS","actual":"$1.16","expected":"N/A","surprise":"+14.97%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Eli Lilly's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 3.06% increase. However, without revenue figures or management commentary, investors may have limited insight into the company's overall performance and future outlook.","metaDescription":"Eli Lilly (LLY) Q2 2013 earnings: EPS beat by 14.97%. Stock up 3.06%. Full breakdown."}}